SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Intensive Care Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Shochet, R. B.
Right arrow Articles by Murray, G. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shochet, R. B.
Right arrow Articles by Murray, G. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Analytic Reviews : Neuropsychiatric Toxicity of Meperidine

Robert B. Shochet, MD

Psychiatric Consultation Service, Massachusetts General Hospital, Boston, MA

George B. Murray, MD

Psychiatric Consultation Service, Massachusetts General Hospital, Boston, MA

The use of meperidine can lead to neuropsychiatric tox icity manifested by excitatory states and seizure. Nor meperidine, an active metabolite, is the agent responsi ble for this toxicity; its long half-life of elimination allows for significant accumulation with repeated dosing of the parent compound. Normeperidine is proconvul sant, and this property alone may account for the toxic symptoms. Psychiatric symptoms often herald the onset of toxicity and may be the result of complex partial seizure. A pathophysiological mechanism of toxicity is suggested, and management of the toxic patient is dis cussed.

Journal of Intensive Care Medicine, Vol. 3, No. 5, 246-252 (1988)
DOI: 10.1177/088506668800300506
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
D. Ross-Degnan, S. B. Soumerai, E. E. Fortess, and J. H. Gurwitz
Examining Product Risk in Context: Market Withdrawal of Zomepirac as a Case Study
JAMA, October 27, 1993; 270(16): 1937 - 1942.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
J. D. Tobias and D. K. Baker
Patient-Controlled Analgesia With Fentanyl in Children
Clinical Pediatrics, March 1, 1992; 31(3): 177 - 179.
[PDF]

Home page
 J Intensive Care MedHome page
T. A Stern
Neuropsychiatric Effects of Narcotic Analgesia: Stern TA. Neuropsychiatric effects of narcotic analgesia. J In tensive Care Med 1988;3:237-238
J Intensive Care Med, September 1, 1988; 3(5): 237 - 238.
[PDF]


Advertisement